A man who has packed school lunches, sat through orthodontist appointments, and learned every line of a favorite Pixar movie ...

Some people get drunk without drinking because their gut bacteria produce alcohol from food. Researchers have now identified ...

AI drug discovery startup Converge Bio raised $25 million in a Series A led by Bessemer Venture Partners, with additional ...

India's bio-CNG industry is calling for assured long-term offtake arrangements, consistent policy support and faster approvals to scale decentralised plants nationwide, as these measures are critical ...

New Delhi [India], January 1 (ANI): India's bio-CNG industry is calling for assured long-term offtake arrangements, consistent policy support and faster approvals to scale decentralised plants ...

Jennifer Simonson is a business journalist with a decade of experience covering entrepreneurship and small business. Drawing on her background as a founder of multiple startups, she writes for Forbes ...

Akebia Therapeutics has struck a deal for Q32 Bio’s deprioritized complement inhibitor ADX-097, paying $7 million upfront for an asset that forms the centerpiece of its new rare kidney disease ...

KALA BIO Inc. (NASDAQ: KALA) jumped 37.87% to $0.88 in after-hours trading on Tuesday. Check out the current price of KALA stock here. According to Benzinga Pro data, the stock closed the regular ...

Pithy yet powerful, the Instagram bio can turn a casual scroller into an engaged follower—or send them straight to the back button. Let’s dive into the do’s and don’ts of crafting a bio that actually ...

Francis Crick missed a crucial seminar in 1951, probably because he was seeing a lover. James Watson did go, failed to take notes and misremembered key details. As a result, their first model of DNA ...

An illustration of a protein created by Accipiter Bio that has two active sites, shown in light and darker green, that can simultaneously bind two targets. (Accipiter Bio Image) A Seattle biotech ...

The use of B-cell–depleting antibodies for autoimmune disease has been well validated with significant use of Roche Holdings AG (OTC:RHHBY) and Biogen Inc (NASDAQ:BIIB) partnered Rituxan (rituximab) ...